Skip to main content
. 2019 Mar 28;11(4):438. doi: 10.3390/cancers11040438

Table 5.

Frequency of NKG2D Hb-2 haplotypes in healthy controls and melanoma patients.

NKG2D Hb-2
Haplotype
Controls Melanoma Patients
Total p/Pc (X2)
NK-1 0.717 0.732 0.63 (0.23)
NK-2 0.240 0.197 0.13 (2.30)
NK-3 0.000 0.039 0.00009/0.0006 (15.25)
NK-4 0.013 0.024 0.24 (1.35)
NK-5 0.015 0.004 0.10 (2.69)
NK-6 0.012 0.004 0.19 (1.67)
NK-7 0.003 0.000 0.31 (1.04)

Healthy controls and melanoma patients (N = 400 and N = 466 chromosomes respectively). p-value was determined by chi-squared test.